Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Fromm

Showing results (181-190 of 247) with videos related to

Pageof 25
Sort By:
Cardiovascular Diabetology|January 7, 2022
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkersArne Gessner, Anna Gemeinhardt, Agnes Bosch, et al.
Pharmacogenetics|July 31, 2004
Lipid-lowering response to statins is affected by CYP3A5 polymorphismKari T Kivistö, Mikko Niemi, Elke Schaeffeler, et al.
Studies in Health Technology and Informatics|August 28, 2014
The effect object paradigm--a means to support medication safety with clinical decision supportAndrius Patapovas, Barbara Pfistermeister, Aleksey Tarkhov, et al.
Pharmacogenetics and Genomics|June 14, 2008
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1Stefan Oswald, Jörg König, Dieter Lütjohann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2007
The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3Annick Seithel, Sonja Eberl, Katrin Singer, et al.
Pharmacological Reviews|December 29, 2019
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic DiseaseTina Schumann, Jörg König, Christine Henke, et al.
Clinical Pharmacology and Therapeutics|January 13, 2023
N<sup>1</sup> -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and ProbenecidFabian Müller, Kathrin Hohl, Sascha Keller, et al.
Cancer Biology & Therapy|February 1, 2011
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissueJuergen Kindla, Tilman T Rau, Rudolf Jung, et al.
British Journal of Clinical Pharmacology|April 23, 2020
Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteersShingen Misaka, Osamu Abe, Tomoyuki Ono, et al.
Molecular Pharmacology|September 27, 2022
Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitorsBastian Haberkorn, Stefan Oswald, Niklas Kehl, et al.
Pageof 25

Showing results (181-190 of 247) with videos related to

Sort By:
Pageof 25
Cardiovascular Diabetology|January 7, 2022
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkersArne Gessner, Anna Gemeinhardt, Agnes Bosch, et al.
Pharmacogenetics|July 31, 2004
Lipid-lowering response to statins is affected by CYP3A5 polymorphismKari T Kivistö, Mikko Niemi, Elke Schaeffeler, et al.
Studies in Health Technology and Informatics|August 28, 2014
The effect object paradigm--a means to support medication safety with clinical decision supportAndrius Patapovas, Barbara Pfistermeister, Aleksey Tarkhov, et al.
Pharmacogenetics and Genomics|June 14, 2008
Disposition of ezetimibe is influenced by polymorphisms of the hepatic uptake carrier OATP1B1Stefan Oswald, Jörg König, Dieter Lütjohann, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 14, 2007
The influence of macrolide antibiotics on the uptake of organic anions and drugs mediated by OATP1B1 and OATP1B3Annick Seithel, Sonja Eberl, Katrin Singer, et al.
Pharmacological Reviews|December 29, 2019
Solute Carrier Transporters as Potential Targets for the Treatment of Metabolic DiseaseTina Schumann, Jörg König, Christine Henke, et al.
Clinical Pharmacology and Therapeutics|January 13, 2023
N<sup>1</sup> -Methylnicotinamide as Biomarker for MATE-Mediated Renal Drug-Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and ProbenecidFabian Müller, Kathrin Hohl, Sascha Keller, et al.
Cancer Biology & Therapy|February 1, 2011
Expression and localization of the uptake transporters OATP2B1, OATP3A1 and OATP5A1 in non-malignant and malignant breast tissueJuergen Kindla, Tilman T Rau, Rudolf Jung, et al.
British Journal of Clinical Pharmacology|April 23, 2020
Effects of single green tea ingestion on pharmacokinetics of nadolol in healthy volunteersShingen Misaka, Osamu Abe, Tomoyuki Ono, et al.
Molecular Pharmacology|September 27, 2022
Cancer-type organic anion transporting polypeptide 1B3 (Ct-OATP1B3) is localized in lysosomes and mediates resistance against kinase inhibitorsBastian Haberkorn, Stefan Oswald, Niklas Kehl, et al.
Pageof 25